INTRODUCTION
In recent years, there haS been a huge increase in the use of antineoplastic agents. The past 20 (3, 4) . The mutagenicity of these drugs has long been regarded as of little risk to any but the patients. However, increasing exposure and handling of these drugs by staff has led to growing concern over the past few years about the long term potential hazard of low level exposure to cytotoxic drugs (7, 8) . The possibility of health hazard from handling antineoplastic drugs was first raised in 1970 (7) . The above the mean was 13. Table II 
